SCHEMBL6232598

SCHEMBL6232598

CCOC(=O)CC1c2c(F)cccc2C(=O)N1CC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.39
IDO1 P14902 1/20 0.39
ALDH1A1 P00352 5/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
ATM Q13315 1/20 0.38
BRD4 O60885 1/20 0.37
PIN1 Q13526 1/20 0.37
PIN4 Q9Y237 1/20 0.37
NLRP3 Q96P20 1/20 0.37
KDM4E B2RXH2 3/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4483188 0.85 TRPA1 (0.46) TRPA1IDO1ALDH1A1MAPTKMT2A
SCHEMBL27528478 0.81 IDO1 (0.52) IDO1ALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL13708565 0.79 TRPA1 (0.39) TRPA1IDO1ALDH1A1HTTKDM4E
SCHEMBL4459488 0.78 TRPA1 (0.38) TRPA1IDO1ALDH1A1MAPTKDM4E
SCHEMBL27552574 0.77 ALDH1A1 (0.44) IDO1ALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL28746674 0.77 IDO1 (0.40) IDO1ALDH1A1HSD17B10CYP1A2MAPT
SCHEMBL27528492 0.76 TRPA1 (0.40) TRPA1ALDH1A1MAPTKMT2AMEN1
SCHEMBL4473541 0.76 TRPA1 (0.44) TRPA1ALDH1A1MAPTKDM4ECA2
SCHEMBL6233955 0.76 TRPA1 (0.44) TRPA1ALDH1A1MAPTKDM4ECA2
SCHEMBL27528482 0.76 ALDH1A1 (0.39) IDO1ALDH1A1HSD17B10CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1290833-C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris SANOFI AVENTIS PHARMA GMBH (DE) 2006-12-20 CN disclosed
EP-1528923-A1 N-((3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL)ACETYL)GUANIDINE DERIVATIVES AS NHE1-INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS Aventis Pharma Deutschland GmbH (DE) 2005-05-11 EP disclosed
WO-2003101450-A1 N- ((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYL) GUANIDINE DERIVATIVES AS NHE-1 INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed